Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes
A reduced eGFR (between 30 and 90 mL/min/1.73 m2) alone was not associated with increased DKA risk. This finding supports further research into potential kidney-protection benefits of SGLTi for selected individuals with type 1 diabetes.
Authors
- Aman Saleemi
- Priya Bapat
- Bruce A. Perkins
- Dalton Budhram
- Andrej Orszag
- Leif Erik Lovblom
- Mary Rose Waniss
- Natasha J. Verhoeff
- Alanna Weisman
- George Tomlinson
- Doug Mumford
- Yucheng Zhang
- David Z.I. Cherney
- Wajeeha Cheema
- Abdulmohsen Bakhsh
- Michael Fralick
- Mohammad I. Abuabat
- Jean-Philippe Ouimet
Institutions
- University Health Network (CA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- University of Toronto (CA)
- Wayne State University (US)
- Lunenfeld-Tanenbaum Research Institute (CA)
- King Faisal Specialist Hospital & Research Centre (SA)
- Diabetes Canada (CA)
- Prince Mohammed bin Abdulaziz Hospital (SA)
- Sinai Health System (CA)
- King Abdulaziz Hospital (SA)
- Institute for Work & Health (CA)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-01-27
- DOI
- https://doi.org/10.2337/dc25-1955
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00